Q1 2014 Holdings
Filed 2014-05-15 | 16 holdings | $193.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medivation, Inc. | Com | 58501N101 | $146.7K | 2,279,519 | 75.9% |
| Ampio Pharmaceuticals Inc. | Com | 03209T109 | $18.8K | 2,964,401 | 9.7% |
| Alcobra Ltd | SHS | M2239P109 | $12.5K | 687,000 | 6.5% |
| Synthetic Biologics Inc. | COM | 87164U102 | $3.5K | 1,360,000 | 1.8% |
| Keryx Biopharmaceuticals Inc. | Com | 492515101 | $3.4K | 200,000 | 1.8% |
| Newlink Genetics Corp | Com | 651511107 | $2.2K | 77,437 | 1.1% |
| Northwest Biotherapeutics Inc(NWBO) | COM PAR $0.001 | 66737P600 | $1.5K | 200,300 | 0.8% |
| Inovio Pharmaceuticals Inc. | COM | 45773H102 | $1.4K | 408,352 | 0.7% |
| Merrimack Pharmaceuticals Inc. | COM | 590328100 | $809 | 160,585 | 0.4% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $746 | 65,000 | 0.4% |
| Advaxis Inc. | COM NEW | 7624208 | $706 | 225,000 | 0.4% |
| Nephrogenex INc | COMM | 640667101 | $412 | 50,000 | 0.2% |
| Parkervision Inc. | COM | 701354102 | $240 | 50,000 | 0.1% |
| Celsus Therapeutics Plc | SPONSORED ADR NE | 15119A202 | $151 | 23,255 | 0.1% |
| Advaxis Inc. | W EXP 07/15/201 | 7624117 | $141 | 112,500 | 0.1% |
| Echo Therapeutics Inc. | Com New | 27876L206 | $86 | 28,630 | 0.0% |